Head of Subproject P08:

Fritz Aberger
Department of Biosciences and Medical Biology
University of Salzburg
Hellbrunner Straße 34
5020 Salzburg
Tel.: +43 662 8044-5792
Email:
Web: www.plus.ac.at/aberger
ORCID:  0000-0003-2009-6305

The main focus of the Aberger group is to understand the intricate molecular and cellular communication processes in the context of malignant development. The laboratory studies therapeutically relevant cancer signaling pathways (e.g. Hedgehog/GLI and JAK/STAT signaling), their cross-talk and integration with other oncogenic cues, including inflammatory signals, and their role in modulating the tumor microenvironment and the anti-tumor immune response. This understanding will inform the design of innovative and improved combination therapies for cancer patients.